HEADER TRANSPORT PROTEIN 07-DEC-24 9KXX TITLE INWARD-OPEN STRUCTURE OF HUMAN B0AT1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SOLUTE CARRIER FAMILY 6 MEMBER 19,SYSTEM B(0) NEUTRAL AMINO COMPND 5 ACID TRANSPORTER AT1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC6A19, B0AT1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS AMINO ACID TRANSPORTER, SLC6, TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR T.IMAZU,I.MIYAGUCHI,M.HIRAIZUMI REVDAT 1 10-DEC-25 9KXX 0 JRNL AUTH T.IMAZU,T.AKASHI,M.HIRAIZUMI,Y.INUI,W.SASAKI,T.TAKAHASHI, JRNL AUTH 2 H.TODOROKI,T.KUMANOMIDOU,H.HISANO,H.ASADA,T.KUSAKIZAKO, JRNL AUTH 3 T.NISHIZAWA,S.IWATA,O.NUREKI,I.MIYAGUCHI JRNL TITL STRUCTURE-GUIDED DEVELOPMENT OF A POTENT HUMAN B0AT1 JRNL TITL 2 INHIBITOR EFFECTIVE IN A MOUSE MODEL OF PHENYLKETONURIA JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : REFMAC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.770 REMARK 3 NUMBER OF PARTICLES : 125620 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9KXX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-DEC-24. REMARK 100 THE DEPOSITION ID IS D_1300054239. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : BINARY COMPLEX OF B0AT1 AND REMARK 245 ANTIBODY REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1600.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 760.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 7 REMARK 465 ASN A 8 REMARK 465 PRO A 9 REMARK 465 GLY A 10 REMARK 465 LEU A 11 REMARK 465 ASP A 12 REMARK 465 ALA A 13 REMARK 465 ARG A 14 REMARK 465 GLU A 27 REMARK 465 GLU A 28 REMARK 465 ALA A 29 REMARK 465 SER A 30 REMARK 465 SER A 31 REMARK 465 ARG A 32 REMARK 465 PRO A 33 REMARK 465 LYS A 34 REMARK 465 TRP A 35 REMARK 465 ASP A 36 REMARK 465 ASN A 37 REMARK 465 LYS A 38 REMARK 465 PHE A 337 REMARK 465 SER A 338 REMARK 465 THR A 339 REMARK 465 ASN A 340 REMARK 465 ILE A 341 REMARK 465 LEU A 342 REMARK 465 THR A 343 REMARK 465 LEU A 344 REMARK 465 ILE A 345 REMARK 465 ASN A 346 REMARK 465 GLY A 347 REMARK 465 PHE A 348 REMARK 465 ASP A 349 REMARK 465 LEU A 350 REMARK 465 PRO A 351 REMARK 465 GLU A 352 REMARK 465 GLY A 353 REMARK 465 ASN A 354 REMARK 465 VAL A 355 REMARK 465 THR A 356 REMARK 465 GLN A 357 REMARK 465 GLU A 358 REMARK 465 ASN A 359 REMARK 465 PHE A 360 REMARK 465 VAL A 361 REMARK 465 ASP A 362 REMARK 465 MET A 363 REMARK 465 GLN A 364 REMARK 465 GLN A 365 REMARK 465 ARG A 366 REMARK 465 CYS A 367 REMARK 465 ASN A 368 REMARK 465 ALA A 369 REMARK 465 SER A 370 REMARK 465 ASP A 371 REMARK 465 PRO A 372 REMARK 465 ALA A 373 REMARK 465 ALA A 374 REMARK 465 TYR A 375 REMARK 465 ALA A 376 REMARK 465 GLN A 377 REMARK 465 LEU A 378 REMARK 465 VAL A 379 REMARK 465 PHE A 380 REMARK 465 GLN A 381 REMARK 465 THR A 382 REMARK 465 CYS A 383 REMARK 465 ALA A 610 REMARK 465 GLN A 611 REMARK 465 LYS A 612 REMARK 465 PRO A 613 REMARK 465 GLY A 614 REMARK 465 ASP A 615 REMARK 465 HIS A 616 REMARK 465 GLN A 617 REMARK 465 GLY A 618 REMARK 465 LEU A 619 REMARK 465 VAL A 620 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 159 42.98 38.06 REMARK 500 THR A 180 -63.36 -100.29 REMARK 500 SER A 184 -141.80 -78.49 REMARK 500 SER A 192 -168.37 -113.91 REMARK 500 ARG A 214 -47.21 -130.58 REMARK 500 TRP A 453 110.86 -38.34 REMARK 500 TYR A 488 -56.25 -125.87 REMARK 500 SER A 491 -100.84 -144.38 REMARK 500 VAL A 508 -61.87 -91.05 REMARK 500 VAL A 536 -74.53 -123.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-62631 RELATED DB: EMDB REMARK 900 INWARD-OPEN STRUCTURE OF HUMAN B0AT1 DBREF 9KXX A 8 620 UNP Q695T7 S6A19_HUMAN 8 620 SEQADV 9KXX MET A 7 UNP Q695T7 INITIATING METHIONINE SEQADV 9KXX LEU A 81 UNP Q695T7 GLU 81 CONFLICT SEQADV 9KXX ILE A 114 UNP Q695T7 LEU 114 CONFLICT SEQADV 9KXX ALA A 290 UNP Q695T7 SER 290 CONFLICT SEQADV 9KXX LEU A 471 UNP Q695T7 PHE 471 CONFLICT SEQADV 9KXX ALA A 500 UNP Q695T7 CYS 500 CONFLICT SEQADV 9KXX TRP A 507 UNP Q695T7 TYR 507 CONFLICT SEQADV 9KXX LEU A 542 UNP Q695T7 MET 542 CONFLICT SEQADV 9KXX ALA A 610 UNP Q695T7 CYS 610 CONFLICT SEQRES 1 A 614 MET ASN PRO GLY LEU ASP ALA ARG ILE PRO SER LEU ALA SEQRES 2 A 614 GLU LEU GLU THR ILE GLU GLN GLU GLU ALA SER SER ARG SEQRES 3 A 614 PRO LYS TRP ASP ASN LYS ALA GLN TYR MET LEU THR CYS SEQRES 4 A 614 LEU GLY PHE CYS VAL GLY LEU GLY ASN VAL TRP ARG PHE SEQRES 5 A 614 PRO TYR LEU CYS GLN SER HIS GLY GLY GLY ALA PHE MET SEQRES 6 A 614 ILE PRO PHE LEU ILE LEU LEU VAL LEU LEU GLY ILE PRO SEQRES 7 A 614 LEU LEU TYR LEU GLU PHE ALA ILE GLY GLN ARG LEU ARG SEQRES 8 A 614 ARG GLY SER LEU GLY VAL TRP SER SER ILE HIS PRO ALA SEQRES 9 A 614 LEU LYS GLY ILE GLY LEU ALA SER MET LEU THR SER PHE SEQRES 10 A 614 MET VAL GLY LEU TYR TYR ASN THR ILE ILE SER TRP ILE SEQRES 11 A 614 MET TRP TYR LEU PHE ASN SER PHE GLN GLU PRO LEU PRO SEQRES 12 A 614 TRP SER ASP CYS PRO LEU ASN GLU ASN GLN THR GLY TYR SEQRES 13 A 614 VAL ASP GLU CYS ALA ARG SER SER PRO VAL ASP TYR PHE SEQRES 14 A 614 TRP TYR ARG GLU THR LEU ASN ILE SER THR SER ILE SER SEQRES 15 A 614 ASP SER GLY SER ILE GLN TRP TRP MET LEU LEU CYS LEU SEQRES 16 A 614 ALA CYS ALA TRP SER VAL LEU TYR MET CYS THR ILE ARG SEQRES 17 A 614 GLY ILE GLU THR THR GLY LYS ALA VAL TYR ILE THR SER SEQRES 18 A 614 THR LEU PRO TYR VAL VAL LEU THR ILE PHE LEU ILE ARG SEQRES 19 A 614 GLY LEU THR LEU LYS GLY ALA THR ASN GLY ILE VAL PHE SEQRES 20 A 614 LEU PHE THR PRO ASN VAL THR GLU LEU ALA GLN PRO ASP SEQRES 21 A 614 THR TRP LEU ASP ALA GLY ALA GLN VAL PHE PHE SER PHE SEQRES 22 A 614 SER LEU ALA PHE GLY GLY LEU ILE SER PHE ALA SER TYR SEQRES 23 A 614 ASN SER VAL HIS ASN ASN CYS GLU LYS ASP SER VAL ILE SEQRES 24 A 614 VAL SER ILE ILE ASN GLY PHE THR SER VAL TYR VAL ALA SEQRES 25 A 614 ILE VAL VAL TYR SER VAL ILE GLY PHE ARG ALA THR GLN SEQRES 26 A 614 ARG TYR ASP ASP CYS PHE SER THR ASN ILE LEU THR LEU SEQRES 27 A 614 ILE ASN GLY PHE ASP LEU PRO GLU GLY ASN VAL THR GLN SEQRES 28 A 614 GLU ASN PHE VAL ASP MET GLN GLN ARG CYS ASN ALA SER SEQRES 29 A 614 ASP PRO ALA ALA TYR ALA GLN LEU VAL PHE GLN THR CYS SEQRES 30 A 614 ASP ILE ASN ALA PHE LEU SER GLU ALA VAL GLU GLY THR SEQRES 31 A 614 GLY LEU ALA PHE ILE VAL PHE THR GLU ALA ILE THR LYS SEQRES 32 A 614 MET PRO LEU SER PRO LEU TRP SER VAL LEU PHE PHE ILE SEQRES 33 A 614 MET LEU PHE CYS LEU GLY LEU SER SER MET PHE GLY ASN SEQRES 34 A 614 MET GLU GLY VAL VAL VAL PRO LEU GLN ASP LEU ARG VAL SEQRES 35 A 614 ILE PRO PRO LYS TRP PRO LYS GLU VAL LEU THR GLY LEU SEQRES 36 A 614 ILE CYS LEU GLY THR PHE LEU ILE GLY LEU ILE PHE THR SEQRES 37 A 614 LEU ASN SER GLY GLN TYR TRP LEU SER LEU LEU ASP SER SEQRES 38 A 614 TYR ALA GLY SER ILE PRO LEU LEU ILE ILE ALA PHE ALA SEQRES 39 A 614 GLU MET PHE SER VAL VAL TRP VAL TYR GLY VAL ASP ARG SEQRES 40 A 614 PHE ASN LYS ASP ILE GLU PHE MET ILE GLY HIS LYS PRO SEQRES 41 A 614 ASN ILE PHE TRP GLN VAL THR TRP ARG VAL VAL SER PRO SEQRES 42 A 614 LEU LEU LEU LEU ILE ILE PHE LEU PHE PHE PHE VAL VAL SEQRES 43 A 614 GLU VAL SER GLN GLU LEU THR TYR SER ILE TRP ASP PRO SEQRES 44 A 614 GLY TYR GLU GLU PHE PRO LYS SER GLN LYS ILE SER TYR SEQRES 45 A 614 PRO ASN TRP VAL TYR VAL VAL VAL VAL ILE VAL ALA GLY SEQRES 46 A 614 VAL PRO SER LEU THR ILE PRO GLY TYR ALA ILE TYR LYS SEQRES 47 A 614 LEU ILE ARG ASN HIS ALA GLN LYS PRO GLY ASP HIS GLN SEQRES 48 A 614 GLY LEU VAL HET NAG B 1 14 HET NAG B 2 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 2(C8 H15 N O6) HELIX 1 AA1 SER A 17 GLU A 25 1 9 HELIX 2 AA2 GLN A 40 PHE A 48 1 9 HELIX 3 AA3 GLY A 51 TRP A 56 1 6 HELIX 4 AA4 TRP A 56 SER A 64 1 9 HELIX 5 AA5 GLY A 67 LEU A 81 1 15 HELIX 6 AA6 LEU A 81 ARG A 97 1 17 HELIX 7 AA7 GLY A 99 HIS A 108 1 10 HELIX 8 AA8 PRO A 109 LEU A 111 5 3 HELIX 9 AA9 LYS A 112 ASN A 142 1 31 HELIX 10 AB1 VAL A 163 SER A 169 1 7 HELIX 11 AB2 SER A 170 ARG A 178 1 9 HELIX 12 AB3 GLN A 194 ARG A 214 1 21 HELIX 13 AB4 ARG A 214 SER A 227 1 14 HELIX 14 AB5 THR A 228 THR A 243 1 16 HELIX 15 AB6 GLY A 246 LEU A 254 1 9 HELIX 16 AB7 ASN A 258 ALA A 263 1 6 HELIX 17 AB8 ASP A 266 SER A 280 1 15 HELIX 18 AB9 GLY A 284 SER A 291 1 8 HELIX 19 AC1 ASN A 298 CYS A 336 1 39 HELIX 20 AC2 ILE A 385 GLU A 391 1 7 HELIX 21 AC3 GLY A 397 LYS A 409 1 13 HELIX 22 AC4 LEU A 412 ARG A 447 1 36 HELIX 23 AC5 PRO A 454 LEU A 475 1 22 HELIX 24 AC6 SER A 477 GLY A 490 1 14 HELIX 25 AC7 SER A 491 VAL A 508 1 18 HELIX 26 AC8 GLY A 510 GLY A 523 1 14 HELIX 27 AC9 ASN A 527 VAL A 536 1 10 HELIX 28 AD1 VAL A 536 VAL A 554 1 19 HELIX 29 AD2 TRP A 581 ALA A 590 1 10 HELIX 30 AD3 GLY A 591 ASN A 608 1 18 SHEET 1 AA1 2 THR A 559 ILE A 562 0 SHEET 2 AA1 2 GLN A 574 SER A 577 -1 O ILE A 576 N TYR A 560 SSBOND 1 CYS A 153 CYS A 166 1555 1555 2.04 LINK ND2 ASN A 258 C1 NAG B 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 TER 4257 HIS A 609 HETATM 4258 C1 NAG B 1 142.139 156.662 172.294 1.00 32.70 C HETATM 4259 C2 NAG B 1 143.199 156.210 173.295 1.00 31.02 C HETATM 4260 C3 NAG B 1 144.066 157.403 173.695 1.00 30.26 C HETATM 4261 C4 NAG B 1 144.622 158.113 172.472 1.00 30.20 C HETATM 4262 C5 NAG B 1 143.508 158.449 171.493 1.00 30.28 C HETATM 4263 C6 NAG B 1 144.009 158.990 170.177 1.00 30.22 C HETATM 4264 C7 NAG B 1 141.341 155.754 174.828 1.00 30.18 C HETATM 4265 C8 NAG B 1 141.048 156.942 175.707 1.00 30.15 C HETATM 4266 N2 NAG B 1 142.614 155.586 174.471 1.00 30.27 N HETATM 4267 O3 NAG B 1 145.116 156.951 174.544 1.00 30.18 O HETATM 4268 O4 NAG B 1 145.237 159.333 172.886 1.00 30.15 O HETATM 4269 O5 NAG B 1 142.780 157.249 171.181 1.00 31.24 O HETATM 4270 O6 NAG B 1 145.240 158.383 169.798 1.00 30.17 O HETATM 4271 O7 NAG B 1 140.449 155.016 174.433 1.00 30.18 O HETATM 4272 C1 NAG B 2 146.661 159.297 172.671 1.00 30.15 C HETATM 4273 C2 NAG B 2 147.134 160.660 172.182 1.00 30.14 C HETATM 4274 C3 NAG B 2 148.652 160.657 171.994 1.00 30.14 C HETATM 4275 C4 NAG B 2 149.348 160.148 173.249 1.00 30.15 C HETATM 4276 C5 NAG B 2 148.783 158.781 173.621 1.00 30.14 C HETATM 4277 C6 NAG B 2 149.374 158.225 174.895 1.00 30.14 C HETATM 4278 C7 NAG B 2 145.389 161.818 170.925 1.00 30.15 C HETATM 4279 C8 NAG B 2 145.083 162.479 169.616 1.00 30.16 C HETATM 4280 N2 NAG B 2 146.484 161.058 170.950 1.00 30.14 N HETATM 4281 O3 NAG B 2 149.087 161.975 171.676 1.00 30.14 O HETATM 4282 O4 NAG B 2 150.742 160.027 173.002 1.00 30.14 O HETATM 4283 O5 NAG B 2 147.364 158.892 173.830 1.00 30.14 O HETATM 4284 O6 NAG B 2 149.276 159.174 175.955 1.00 30.14 O HETATM 4285 O7 NAG B 2 144.675 161.961 171.910 1.00 30.14 O CONECT 1007 1109 CONECT 1109 1007 CONECT 1835 4258 CONECT 4258 1835 4259 4269 CONECT 4259 4258 4260 4266 CONECT 4260 4259 4261 4267 CONECT 4261 4260 4262 4268 CONECT 4262 4261 4263 4269 CONECT 4263 4262 4270 CONECT 4264 4265 4266 4271 CONECT 4265 4264 CONECT 4266 4259 4264 CONECT 4267 4260 CONECT 4268 4261 4272 CONECT 4269 4258 4262 CONECT 4270 4263 CONECT 4271 4264 CONECT 4272 4268 4273 4283 CONECT 4273 4272 4274 4280 CONECT 4274 4273 4275 4281 CONECT 4275 4274 4276 4282 CONECT 4276 4275 4277 4283 CONECT 4277 4276 4284 CONECT 4278 4279 4280 4285 CONECT 4279 4278 CONECT 4280 4273 4278 CONECT 4281 4274 CONECT 4282 4275 CONECT 4283 4272 4276 CONECT 4284 4277 CONECT 4285 4278 MASTER 212 0 2 30 2 0 0 6 4284 1 31 48 END